v3.26.1
Revenue - Narrative (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2026
USD ($)
segment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Number of reportable segments | segment 4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-07-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Percentage of remaining performance obligation expected to be recognized in period 52.00%
Expected timing of satisfaction period (in months) 24 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-07-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Percentage of remaining performance obligation expected to be recognized in period 18.00%
Expected timing of satisfaction period (in months) 12 months
Diagnostic Products  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 6,200
Medical Devices  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations 455
Pharmaceuticals  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 243